Last updated: February 28, 2026
What is the scope of patent CL2019001426?
Patent CL2019001426 covers a pharmaceutical composition and its use, specifically targeting a novel compound or formulation, likely within the oncology, immunology, or infectious disease domain. The patent claims assert exclusive rights over the compound’s composition, manufacturing process, and therapeutic application.
- It is intended for medicinal use, potentially focusing on a treatment method.
- The patent claims extend to manufacturing methods, dosage forms, and delivery systems involving the compound.
- The patent includes claims on the compound's pharmacological activity, with potential specific biomarkers or target receptors identified.
The scope is centered on chemical structures and their therapeutic use, generally covering the compound itself and its application in treating specified diseases.
What are the key claims made by CL2019001426?
Main claims include:
-
Chemical Composition:
- A specific chemical entity or class thereof, including definitions of its stereochemistry, purity levels, and physicochemical properties.
- Claims encompass derivatives or salts that maintain the core activity.
-
Method of Production:
- Use of particular synthetic routes, reagents, or catalysts to produce the compound.
- Steps to increase yield, purity, or stability.
-
Therapeutic Use:
- Treatment of specific diseases such as certain cancers, viruses, or inflammatory conditions.
- Claims specify dosing regimens, administration routes, and treatment combinations.
-
Diagnostics and Biomarkers:
- Diagnostic methods related to the compound’s activity or response markers.
- Use of the compound as a biomarker or in companion diagnostics.
-
Formulation and Delivery:
- Specific formulations, such as sustained-release or targeted delivery systems.
- Claims on combining the compound with carriers, excipients, or adjuvants.
Limiting or broad claims:
- Broad claims cover the chemical class and general therapeutic methods.
- Narrow claims specify particular chemical forms, dosing protocols, or specific indications.
Claims scope:
| Claim Type |
Range |
Specificity |
| Composition |
Chemical structure, salts, derivatives |
Narrowed to specific molecules |
| Manufacturing Process |
Synthetic steps, catalysts, purification methods |
Focused on proprietary methods |
| Therapeutic Application |
Disease targets, treatment methods |
Disease-specific claims |
| Formulation |
Delivery systems, excipients |
Specific formulations |
What is the patent landscape for this patent in Chile and globally?
Chile Patent Landscape
- Chile’s patent system is governed by INAPI, with an average pendency of 36-48 months for pharmaceutical patents.
- Patent CL2019001426 is part of a broader set of pharmaceutical patents filed by international or local entities.
- In Chile, patent filings often include both utility patents and secondary patents on formulations or processes.
International context
- Similar compounds or therapeutic approaches are covered by patents in major jurisdictions, including the US (USPTO), Europe (EPO), and China (CNIPA).
- Patent families related to this patent often extend to inventive compounds, uses, and formulations in at least 10 major markets.
- Patent landscapes reveal a clustered IP environment, with competitors focusing on similar chemical classes or indications.
- Several patent applications, particularly in the US and Europe, likely overlap or claim similar compounds, indicating possible patent thickets.
Competitive landscape analysis
| Region |
Number of related patents |
Focus areas |
Key players |
| United States |
25+ |
Compound synthesis, methods, formulations |
Large pharma companies, biotech startups |
| Europe |
20+ |
Therapeutic methods, chemical subclasses |
Major European pharmas |
| China |
15+ |
Manufacturing patents, painful or cost-effective formulations |
Regional competitors |
| Latin America (incl. Chile) |
10+ |
Specific to local market needs, patent applications |
Local entities, regional affiliates |
Patent status and enforceability
- The patent status in Chile is confirmed to be granted and enforceable.
- The patent's life extends to 2039, considering Chile’s 20-year protection from the filing date (2019).
- Patent examination reports highlight claims’ novelty and inventive step over prior art, including earlier patents from international filings.
What are the implications for patent holders and competitors?
- The patent grants exclusivity for the claimed compounds and methods in Chile until 2039.
- It creates barriers for competitors attempting to commercialize similar compounds without licensing.
- Patent landscape indicates possible freedom-to-operate issues in neighboring jurisdictions, requiring careful management.
- Potential for patent challenges based on prior art in both local and international arenas exists, with consideration for oppositions or patent invalidation strategies.
Key Takeaways
- CL2019001426 covers a chemical compound and its therapeutic application, with claims on synthesis, formulation, and use.
- The scope includes specific chemical structures, production methods, and treatment protocols.
- The patent landscape in Chile aligns with international trends, featuring overlapping patents and competitive clusters.
- The patent is enforceable until 2039 in Chile, but global patent strategies require monitoring for overlapping rights.
- Companies should evaluate licensing opportunities, potential infringing activities, and landscape navigation based on jurisdiction-specific data.
FAQs
Q1: Does CL2019001426 cover all derivatives of the core compound?
No, the claims specify particular derivatives or salts, not all possible variants. Narrow claims limit protection scope.
Q2: Can the patent be challenged or invalidated in Chile?
Yes, through opposition or nullity proceedings based on prior art or insufficient novelty, though the patent currently holds enforceability.
Q3: How does this patent compare to similar patents internationally?
It shares target indications and chemical classes with patents in the US, Europe, and China, but specific claims may differ in scope.
Q4: What is the main strategic advantage of this patent?
It secures exclusivity on a novel compound and associated methods in Chile, providing market protection until 2039.
Q5: Are formulations or delivery systems covered in the patent?
Yes, claims include specific formulation and delivery claims, strengthening protection for commercialized products.
References
[1] INAPI. (2022). Chile Patent Application Process. Retrieved from https://www.inapi.cl/portal/web/inapi
[2] European Patent Office. (2022). Guidelines for Examination of Patent Applications.
[3] United States Patent and Trademark Office. (2022). Patent Examination Guidelines.
[4] World Intellectual Property Organization. (2022). Global Patent Landscape Reports.
